EXCLUSIVE: Blue State Hospital Bows To DOJ, Ends Trans Procedures For Kids

Connecticut Children’s Medical Center has reached a settlement with the U.S. Department of Justice (DOJ) agreeing to cease performing transgender-related procedures on minors, according to exclusive reporting by The Daily Wire. The agreement marks another step in the DOJ's broader campaign against what it calls "harmful" gender-affirming treatments for children. Under the terms of the deal, Connecticut Children’s will no longer offer puberty blockers, hormone therapy, or surgical interventions aimed at altering a child’s sex characteristics. The hospital will also contribute $500,000 toward providing medical care for individuals who have undergone such procedures and later reversed them, known as detransitioners. The agreement was announced following months of legal proceedings and negotiations. The DOJ, which has been actively pursuing multiple hospitals across the country, cited concerns over the safety and well-being of children. In a statement, Associate Attorney General Stanley Woodward emphasized that the DOJ would continue enforcing federal laws to safeguard minors. He noted that the resolution serves as a warning to healthcare institutions that they must comply with legal standards, particularly when the health of children is at stake. The DOJ's initiative builds upon former President Donald Trump’s 2020 executive order, which instructed federal agencies to reassess the legality of gender-affirming care for minors. That directive led to increased scrutiny of medical facilities offering such services. The current efforts by the DOJ include similar settlements with Texas Children’s Hospital and the Cleveland Clinic Foundation. In both cases, the hospitals agreed to halt certain procedures and provide financial compensation to affected families. The DOJ praised the Cleveland Clinic for its cooperation during the investigation, highlighting its willingness to work with authorities to address the issue. According to documents obtained by The Daily Wire, the DOJ’s case against Connecticut Children’s focused on allegations that the hospital had violated federal law by engaging in what it described as "genital mutilation." The department argued that these procedures pose serious risks to minors and that they should not be performed unless there is clear evidence of harm. The hospital’s decision to settle rather than contest the charges reflects the growing pressure on medical institutions to align with the DOJ’s stance on the matter. Legal experts and advocacy groups have expressed mixed reactions to the developments. Some organizations representing parents and religious communities have welcomed the DOJ’s actions, arguing that the policies protect children from potentially irreversible medical interventions. Others, however, have criticized the approach as overly broad and lacking sufficient scientific backing. Critics argue that the DOJ is using legal tools to suppress legitimate medical care for transgender youth, often without adequate evidence of long-term harm. The DOJ has also pledged to expand its efforts beyond individual hospitals. It plans to prioritize investigations into states that it claims are facilitating illegal medical practices by allowing unauthorized gender-affirming care. This includes potential applications of the Parental Kidnapping Prevention Act, which aims to prevent the removal of children from parental custody based on controversial medical decisions. The DOJ has stated that it will continue working with state officials to ensure compliance with federal law and to protect the rights of parents in making medical decisions for their children. As the DOJ continues its campaign, more hospitals and clinics may face similar demands to adjust their policies. The outcome of these legal actions could shape future regulations around gender-affirming care in the United States, influencing both medical practice and public policy. The focus remains on ensuring that all parties adhere to legal frameworks while addressing the complex ethical and medical considerations surrounding treatment for transgender youth.